GlassScriptPhysician profile
Evelyn Ramos
NPI 1619090099
$604.14
in general payments reported to CMS, 2019-2025
10 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.23 · 2020: $35.67 · 2023: $55.45 · 2024: $331 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $214.91 | 2024-2025 | Xifaxan |
| Boston Scientific Corporation | $91.37 | 2023-2025 | Watchman Flx, Watchman Access System |
| Pfizer INC. | $76.01 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $66.66 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $52.40 | 2020-2024 | Xarelto |
| Ipsen Biopharmaceuticals, INC | $26.72 | 2024 | Bylvay |
| Medtronic, INC. | $25.90 | 2025 | Kyphon Express II Kyphopak Tray |
| E.R. Squibb & Sons, L.L.C. | $21.50 | 2019 | |
| Octapharma USA, INC. | $16.94 | 2025 | Fibryga |
| Viiv Healthcare Company | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evelyn Ramos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.